During the past decade, Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are "Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" in a lesser frequency.

Most popular intervention types in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "Bendamustine" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Obinutuzumab" (1 trials) and "Polatuzumab vedotin (Liquid)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".